YAOPHARMA CO LTD FDA Approval ANDA 072993

ANDA 072993

YAOPHARMA CO LTD

FDA Drug Application

Application #072993

Application Sponsors

ANDA 072993YAOPHARMA CO LTD

Marketing Status

Discontinued001

Application Products

001CAPSULE;ORAL2MG0LOPERAMIDE HYDROCHLORIDELOPERAMIDE HYDROCHLORIDE

FDA Submissions

ORIG1AP1992-08-28
LABELING; LabelingSUPPL2AP1996-07-10
MANUF (CMC); Manufacturing (CMC)SUPPL3AP1996-09-17
MANUF (CMC); Manufacturing (CMC)SUPPL4AP1997-08-08
MANUF (CMC); Manufacturing (CMC)SUPPL5AP1999-05-05
MANUF (CMC); Manufacturing (CMC)SUPPL7AP2000-07-12
MANUF (CMC); Manufacturing (CMC)SUPPL8AP2000-07-12
MANUF (CMC); Manufacturing (CMC)SUPPL9AP2001-11-06
LABELING; LabelingSUPPL13AP2016-11-03STANDARD

Submissions Property Types

SUPPL1Null0
SUPPL3Null0
SUPPL4Null0
SUPPL5Null0
SUPPL7Null0
SUPPL8Null0
SUPPL9Null0
SUPPL13Null15

CDER Filings

YAOPHARMA CO LTD
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 72993
            [companyName] => YAOPHARMA CO LTD
            [docInserts] => ["",""]
            [products] => [{"drugName":"LOPERAMIDE HYDROCHLORIDE","activeIngredients":"LOPERAMIDE HYDROCHLORIDE","strength":"2MG","dosageForm":"CAPSULE;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"LOPERAMIDE HYDROCHLORIDE","submission":"LOPERAMIDE HYDROCHLORIDE","actionType":"2MG","submissionClassification":"CAPSULE;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.